ATE99945T1 - Verwendung von 5'-deoxy-5'-methylthioadenosin s- adenosylmethionin und dessen salzen zur herstellung von seborrhea vermindernden arzneimitteln. - Google Patents

Verwendung von 5'-deoxy-5'-methylthioadenosin s- adenosylmethionin und dessen salzen zur herstellung von seborrhea vermindernden arzneimitteln.

Info

Publication number
ATE99945T1
ATE99945T1 AT90104640T AT90104640T ATE99945T1 AT E99945 T1 ATE99945 T1 AT E99945T1 AT 90104640 T AT90104640 T AT 90104640T AT 90104640 T AT90104640 T AT 90104640T AT E99945 T1 ATE99945 T1 AT E99945T1
Authority
AT
Austria
Prior art keywords
deoxy
seborrhea
reduce
salts
methylthioadenosin
Prior art date
Application number
AT90104640T
Other languages
English (en)
Inventor
Moratti Emanuela Maggioni
Original Assignee
Bioresearch Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioresearch Spa filed Critical Bioresearch Spa
Application granted granted Critical
Publication of ATE99945T1 publication Critical patent/ATE99945T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/606Nucleosides; Nucleotides; Nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/008Preparations for oily hair
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AT90104640T 1989-03-13 1990-03-12 Verwendung von 5'-deoxy-5'-methylthioadenosin s- adenosylmethionin und dessen salzen zur herstellung von seborrhea vermindernden arzneimitteln. ATE99945T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8919737A IT1229477B (it) 1989-03-13 1989-03-13 Impiego di 5' deossi - 5' metiltioadenosina, s adenosilmetionina e dei loro sali per la preparazione di composizioni farmaceutiche atte a ridurre la seborrea e composizioni farmaceutiche relative

Publications (1)

Publication Number Publication Date
ATE99945T1 true ATE99945T1 (de) 1994-01-15

Family

ID=11160803

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90104640T ATE99945T1 (de) 1989-03-13 1990-03-12 Verwendung von 5'-deoxy-5'-methylthioadenosin s- adenosylmethionin und dessen salzen zur herstellung von seborrhea vermindernden arzneimitteln.

Country Status (11)

Country Link
US (1) US5753213A (de)
EP (1) EP0387756B1 (de)
JP (1) JPH0778011B2 (de)
KR (1) KR900013969A (de)
AT (1) ATE99945T1 (de)
CA (1) CA2012046C (de)
DE (1) DE69005860T2 (de)
DK (1) DK0387756T3 (de)
ES (1) ES2062137T3 (de)
IT (1) IT1229477B (de)
ZA (1) ZA901929B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1247903B (it) * 1991-02-25 1995-01-05 Bioresearch Spa Impiego della s-adenosil-l-metionina nel trattamento della colestasi intraepatica da nutrizione parenterale totale
KR100309141B1 (ko) * 1998-04-13 2001-12-28 조영동 5'-데옥시-5'-메틸티오아데노신을이용한면역분석방법
DE10132338A1 (de) * 2001-07-04 2003-01-16 Basf Ag Verwendung von 5'-Desoxy-5'-methylthioadenosin in hautkosmetischen Mitteln
ITMI20012462A1 (it) * 2001-11-22 2003-05-22 Gnosis Srl Processo per la preparazione di compresse comprendenti s-adenosilmetionina
ITMI20032393A1 (it) * 2003-12-05 2005-06-06 Applied Pharma Res Composizioni contenenti metilioadenosina-mta-e loro uso topico.
US7406746B2 (en) * 2004-08-31 2008-08-05 Bushey Richard D Slider for heavy loads
FR2884421B1 (fr) 2005-04-15 2007-08-10 Virbac Sa Nouveaux moyens de regulation des troubles du comportement chez les animaux de compagnie
WO2006111541A2 (en) * 2005-04-20 2006-10-26 Basf Plant Science Gmbh Expression cassettes for seed-preferential expression in plants
US20090088404A1 (en) * 2007-01-31 2009-04-02 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
EP2124552A4 (de) * 2007-01-31 2013-01-09 Methylation Sciences Internat Srl Pharmazeutische formulierung aus s-adenosylmethionin mit verlängerter freisetzung
US20100062993A1 (en) * 2008-09-11 2010-03-11 Yochanan R. Bulka Adenosine Nucleotides as Dietary Supplements and as Agents in the Prevention of Cancer and the Metastasis Thereof
US8329208B2 (en) 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
US20110027342A1 (en) * 2009-07-28 2011-02-03 Msi Methylation Sciences, Inc. S-adenosylmethionine formulations with enhanced bioavailability
WO2014163152A1 (ja) * 2013-04-05 2014-10-09 ライオン株式会社 ノンレム睡眠促進剤、深睡眠促進剤および自然睡眠誘発剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA7467B (en) * 1973-01-16 1974-11-27 J Voorhees Compositions and treatment of proliferative skin diseases with b2 agonists
AR221676A1 (es) * 1974-07-12 1981-03-13 Bioresearch Sas Procedimiento para la preparacion de sales estables sulfonicas y/o sulfuricas de la s-adenosil-l-metionina,particularmente utiles como donadores especificos de metilo para las reacciones bioquimicas de transferencia del grupo ch3;asi como tambien las reacciones fundamentales en el metabolismo lipilico,protilico y glucidico
US4496588A (en) * 1977-07-11 1985-01-29 Merrell Toraude Et Compagnie Method of treating psoriasis
US4373097A (en) * 1981-04-27 1983-02-08 Bioresearch S.R.L. Process for preparing adenosine derivatives of anti-inflammatory and analgesic activity
IT1137640B (it) * 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
JPS59134710A (ja) * 1983-01-21 1984-08-02 Suntory Ltd 発酵養毛化粧料
FR2580478B1 (fr) * 1985-04-17 1989-05-12 Christian Chapoton Dispositif de traitement capillaire liberant une substance active et procede de fabrication
EP0216357A3 (de) * 1985-09-25 1988-08-31 Nippon Zeon Co., Ltd. Phosphoramidit-Verbindungen und Verfahren zu deren Herstellung
GB8607265D0 (en) * 1986-03-24 1986-04-30 London King S College Protecting groups of organic synthesis
ATE87932T1 (de) * 1986-12-02 1993-04-15 Centre Nat Rech Scient Alpha-oligonukleotide.
FR2623396B1 (fr) * 1987-11-25 1990-03-30 Sanofi Sa Utilisation de l'ademetionine contre le vieillissement de la peau

Also Published As

Publication number Publication date
IT8919737A0 (it) 1989-03-13
IT1229477B (it) 1991-09-03
DE69005860D1 (de) 1994-02-24
DK0387756T3 (da) 1994-03-07
ZA901929B (en) 1990-12-28
JPH0368520A (ja) 1991-03-25
EP0387756A1 (de) 1990-09-19
CA2012046A1 (en) 1990-09-13
KR900013969A (ko) 1990-10-22
EP0387756B1 (de) 1994-01-12
DE69005860T2 (de) 1994-04-28
CA2012046C (en) 2001-02-13
ES2062137T3 (es) 1994-12-16
JPH0778011B2 (ja) 1995-08-23
US5753213A (en) 1998-05-19

Similar Documents

Publication Publication Date Title
ATA195588A (de) Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu
DE3883035D1 (de) Saponinkomplexe mit phospholipiden und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
DE3688114D1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
AU4732989A (en) Pyrimidines and their pharmaceutical acceptable salts thereof, and their use as medicines
FI862011A0 (fi) Terapeutiska nukleosider.
ATE99945T1 (de) Verwendung von 5'-deoxy-5'-methylthioadenosin s- adenosylmethionin und dessen salzen zur herstellung von seborrhea vermindernden arzneimitteln.
GR3007790T3 (de)
NL970006I1 (nl) Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson.
FI941245A (fi) Menetelmä 2'-deoksiguanosiinin asyylijohdannaisten valmistamiseksi
ES2037086T3 (es) Procedimiento para preparar formulaciones farmaceuticas.
HK87094A (en) Use of buspirone for preparing pharmaceutical compositions for alleviation of phobic anxiety
ES555118A0 (es) Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas.
ATE110269T1 (de) Ipriflavone enthaltende pharmazeutische zubereitungen, verfahren zur herstellung und therapeutische verwendung.
DE69005160D1 (de) Verwendung von 5'-Deoxy-5'-methylthioadenosin, s-Adenylmethionin und deren Salzen zur Herstellung pharmazeutischer Präparate zur Förderung des Haarwuchses bei Patienten mit Kahlköpfigkeit.
IT8920358A0 (it) Impiego di derivati della fosfatidil carnitina per la preparazione di composizioni farmaceutiche aventi attivita' nella terapia delle patologie dell'uomo associate con un danno neuronale.
DE68927055D1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
DE69003466D1 (de) Substituierte Thienopyrimidin-Derivate, deren Herstellung, pharmazeutische Zusammensetzungen und medizinische Verwendung.
DE3773716D1 (de) Verfahren zur herstellung von monosodiumsalz und dessen monohydrat von 1-beta-d-arabinofuranosylcytosin-5'stearylphosphat und diese enthaltende pharmazeutische zusammensetzung.
IT8821570A0 (it) Impiego di derivati adenosinici per la preparazione di composizioni farmaceutiche aventi attivita' immunostimolante.
HUT71838A (en) Use of biologically active ureido derivatives useful in the treatment of lentivirus-induced disease for producing pharmaceutical compositions
ITMI911445A1 (it) Impiego di derivati fosfolipidici per la preparazione di composizioni farmaceutiche aventi attivita' immunosoppressiva
ATE133177T1 (de) 3'-deamino-4'-deoxy-4'-amino-8-fluoranthracycli e und verfahren zu ihrer herstellung
EP0301239A3 (en) Use of gepirone for preparing pharmaceutical compositions for alleviation of panic disorders
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
AU5127290A (en) Use of 5'deoxy-5'methylthioadenosine, s-adenosylmethionine and their salts in the preparation of seborrhea-reducing pharmaceutical compositions, and the pharmaceutical compositions concerned

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EEFA Change of the company name
EELA Cancelled due to lapse of time